China Matters Documents the Collective Nucleic Acid Testing in Beijing

BEIJING, Oct. 27, 2020 /PRNewswire/ — Collective testing served as a critical approach in China for emergency response in face of the coronavirus outbreak.

In mid-October, a cluster of COVID-19 infections was found in Qingdao.

The local government immediately organized a collective nucleic acid testing for 10 million people within five days.

Back in June, as the cluster of COVID-19 infections linked to Beijing’s Xinfadi Agricultural Produce Wholesale Market emerged, Beijing municipal government started to call on citizens to receive nucleic acid testing.

Up to July 11, 11.88 million people have done the test, accounting for half of the permanent residents in Beijing. The number of testing institutions in Beijing rose to 194 by the end of June, with a daily testing volume of 458,000. It helped a lot to filtrate the infected cases.

Out of the required demand for a trip outside Beijing, British journalist and host Josh from China Matters received nucleic acid testing right as the cluster of new infections was found in Beijing and the whole process was filmed.

This video shows the process of making test appointment online, collecting throat swabs, and receiving report through phones. The first-hand observation and feelings by the host Josh on the spot make the video vivid and unique.

Video – https://mma.prnewswire.com/media/1321162/China_Matters_Testing_COVID_19_Beijing.mp4
Logo – https://healthtechnologynet.com/wp-content/uploads/2020/10/China_Matters_Logo.jpg

Contact: Li Siwei
Tel.: +8610-68996566
E-mail: lisiwei5125@gmail.com
Facebook: https://business.facebook.com/watch/?v=1555325854650363 
YouTube: https://youtu.be/rPRj_wzDreo

View original content to download multimedia:http://www.prnewswire.com/news-releases/china-matters-documents-the-collective-nucleic-acid-testing-in-beijing-301160813.html

SOURCE China Matters

Staff

Recent Posts

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

2 hours ago

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive…

2 hours ago

Therap Services Announces 2026 National Conference Schedule: Highlighting New Tools, Best Practices, and Over 250 Specialized Sessions

TORRINGTON, Conn., Dec. 17, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

2 hours ago

Catalyst by Wellstar Launches Polysight, Bringing Real-Time AI to Healthcare Compliance

The startup was formed to address rising regulatory complexity in healthcare.ATLANTA, Dec. 17, 2025 /PRNewswire/…

2 hours ago

Rockbridge Growth Equity-backed ProSites Acquires GeniusVets, Creating a Comprehensive Veterinary Marketing Platform under its LifeLearn Brand

LifeLearn offers a full suite of website creation, digital marketing, client communications and education, and…

2 hours ago

CORRECTION: TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

PHILADELPHIA, PA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in…

2 hours ago